Private longevity and healthspan programmes have grown considerably in recent years, offering everything from comprehensive blood panels to lifestyle coaching and advanced imaging. The appeal is understandable: many people want a more proactive, personalised approach to their health than routine appointments allow. However, the terminology — “healthspan”, “biological age”, “optimisation” — can obscure meaningful differences between programmes. This guide helps you ask the right questions before committing, understand what these programmes can and cannot tell you, and recognise when findings warrant follow-up with a qualified clinician rather than a programme adjustment.
Understanding What "Healthspan" Actually Means
Healthspan broadly refers to the period of life spent in good functional health — not simply the absence of disease, but the presence of energy, mobility, cognitive clarity, and the capacity to do things that matter to you. The definition is personal and contextual. Meaningful wellbeing and function can coexist with chronic conditions, and a good programme should reflect that nuance rather than treating any deviation from an idealised norm as a problem to fix.
The National Institute on Aging provides information on healthy ageing. When evaluating a programme, consider how its priorities relate to the activities and capacities you value. This matters when evaluating programmes, because some use narrow biomarker targets as proxies for health without accounting for individual variation, life circumstances, or what actually constitutes quality of life for you. Before signing up, ask a programme what their working definition of healthspan is and whether it accommodates your own priorities and existing health conditions.
Screening Versus Diagnosis: A Critical Distinction
Most private longevity programmes offer screening — tests designed to identify potential risk factors or early signals in people who have no current symptoms. Screening is not the same as diagnosis. A screening result that falls outside a reference range does not mean you have a condition; it means further investigation may be warranted. Conflating the two can cause unnecessary anxiety or, conversely, false reassurance when a “normal” result is interpreted as a clean bill of health.
The NHS explains that all screening carries a risk of false positives and false negatives, and that benefits must be weighed against potential harms, including the psychological impact of uncertain results. A credible private programme should explain this clearly upfront. Be cautious of any programme that presents screening findings as definitive or that moves quickly from a result to a treatment recommendation without involving a qualified clinician in the interpretation. Ask specifically: who reviews your results, what are their qualifications, and what is the pathway if something concerning is found?
What Tests and Assessments Are Typically Included
Longevity programmes vary enormously in scope. At the more straightforward end, you might find extended blood panels covering metabolic markers, lipid profiles, inflammatory markers, and hormones. More comprehensive programmes add body composition analysis, cardiovascular fitness testing, cognitive assessments, gut microbiome analysis, or advanced imaging such as whole-body MRI or coronary artery calcium scoring.
Not all of these have the same evidence base. Some markers — blood glucose regulation, blood pressure, lipid profiles — have well-established links to long-term health outcomes. Others, such as certain “biological age” scores derived from epigenetic clocks, are areas of active research rather than established clinical tools. When evaluating a programme, ask which assessments are included and why. A programme that can explain the reasoning behind each test and acknowledge the limits of newer markers is more trustworthy than one that presents every metric as equally actionable. More tests do not automatically mean better information.
Evaluating the Evidence Behind the Interventions
Once a programme has assessed you, it will typically recommend interventions — which might include nutritional guidance, sleep support, exercise frameworks, stress management, or supplementation. The quality of evidence behind these recommendations varies considerably. Lifestyle factors such as regular physical activity, adequate sleep, not smoking, and a broadly nutritious diet have robust, long-standing support from population research. The NIA notes that these fundamentals remain central to healthy ageing.
By contrast, some programmes recommend specific supplements, hormonal protocols, or novel therapies based on preliminary research — animal studies, small trials, or theoretical mechanisms — that has not yet translated into established human clinical practice. Preliminary research can be worth following, but it is not the same as established practice. A trustworthy programme will be transparent about this distinction, using language like “emerging evidence suggests” rather than presenting cutting-edge interventions as proven. If a programme cannot tell you the quality of evidence behind a specific recommendation, treat that as a significant caution.
Questions to Ask Before You Commit
Before enrolling in any programme, a structured set of questions will help you assess its credibility and suitability. Consider asking the following:
- Who are the clinicians involved, and what are their qualifications and regulatory registrations?
- How are results interpreted — by an algorithm, a clinician, or both?
- What happens if a result suggests something that needs urgent medical attention?
- Is the programme designed to complement your existing NHS or primary care relationship, or does it position itself as a replacement?
- How does the programme handle pre-existing conditions or medications that may affect test results?
- What is the follow-up structure, and how are recommendations adjusted over time?
The answers reveal whether a programme treats you as an individual with a health history or as a generic participant in a standardised protocol. A programme that encourages you to share findings with your GP and that has a clear escalation pathway for concerning results is operating responsibly.
General Wellbeing Versus Medical Treatment
Many longevity programmes sit in a space between general wellbeing and medical treatment, and it is important to understand which side of that line a given programme occupies. Wellbeing services — coaching, lifestyle guidance, nutritional education — do not require medical regulation in the same way that diagnosis and treatment do. This is not inherently problematic, but it means you should not expect them to carry the same accountability structures as regulated healthcare.
If a programme recommends something that constitutes medical treatment — prescribing medication, administering injections, or managing a clinical condition — it should be operating under appropriate regulatory oversight. Ask which professional registrations are relevant to the clinician and the location where care is delivered, and verify them independently. If you are uncertain whether a recommendation crosses into medical territory, discuss it with your GP before proceeding. This is especially important if you have existing health conditions, take regular medications, or are pregnant.
Interpreting Results With Appropriate Caution
Receiving a set of results from a longevity programme can feel clarifying, but interpretation requires care. Reference ranges used by private programmes may differ from those used in clinical practice, and a result described as “suboptimal” may still fall within a clinically normal range. Conversely, a result flagged as normal does not rule out all health concerns — it simply means the specific markers tested did not show a signal on that occasion.
Be particularly cautious with composite scores such as “biological age” or “health age” metrics. These are calculated using various algorithms and can vary significantly between providers using the same underlying data. They may be motivating as a rough guide, but they should not be treated as precise clinical measurements. If a result concerns you — whether it is flagged as abnormal or you simply do not understand what it means — the appropriate next step is to discuss it with a qualified clinician, not to adjust a supplement stack or change a protocol unilaterally.
When to Involve Your GP or a Specialist
A private longevity programme should complement, not replace, your relationship with NHS or primary care services. There are specific circumstances where involving your usual clinician is particularly important. If a programme identifies a result that it describes as potentially significant — a finding that the assessing clinician recommends investigating — you should share this with your GP promptly, bringing the full results report rather than a summary.
More broadly, if you are managing a long-term condition, your GP needs to know about any new supplements or interventions a programme recommends, as these can interact with medications or affect how your condition is monitored. Escalation is also appropriate if you feel pressured by a programme to make rapid decisions, if recommendations seem to conflict with advice from your existing clinicians, or if a programme discourages you from seeking a second opinion. Healthy scepticism is not disloyalty to a programme — it is good health literacy.
How does SENSES approach healthspan?
SENSES connects individual medical assessment with interpretation and practical priorities. The one- and two-week programmes are designed for medically stable people who want time to understand relevant findings and consider routines for everyday life. One week focuses on assessment and priorities; two weeks adds time for supported practice and refinement.
Your history and questions guide the assessment. The written proposal confirms the selected professionals, services, and arrangements. A programme description is not a promise of a particular health outcome.
